Search Results

Check out our latest collection of 25 cutting-edge research papers on GPCRs and exciting updates on industry Jianming Han, Tao Che for their analysis of GPCR-G protein selectivity revealed by structural pharmacology assays in drug discovery October 2024 | Biologics US 2024 October 2 - 4, 2024 | 9th GPCRs in Medicinal Chemistry

That simple ask pulled a young chemist out of the fume hood and into the messy, electrifying world of Chemical probes offered a solution. Chemical probes may be elegant, but biology isn’t. Tissue is messy. JB brought chemical intuition and a love for toolmaking. That chemistry — human chemistry — is what allowed the science to move as quickly as it did.

Pipeline Efficiency Begins With the Chemistry Itself Drug discovery pipelines often stall not because the target is wrong—but because the chemical matter  interacting with that target lacks the right properties In this lesson, you’ll gain: A strategic view of how chemical scaffolds shape pharmacologic outcomes And occasionally, new chemistry emerges from an unexpected source: Side effects. Informatics Expands the Search Space for Chemical Drug Matter Advances in chemoinformatics  introduced

Chemical biologist Johannes Broichhagen reveals how fluorescent probes transform GPCR imaging, internalization GPCR Podcast, chemical biologist Dr. Why this matters How a chemist with zero biology training became a leader in GPCR probe design. , peptide chemistry, and advanced imaging. His lab integrates synthetic chemistry, theoretical chemistry, cell biology, and imaging to understand

Ross Cheloha About this episode Dr. Ross Cheloha is an Investigator at the National Institutes of Health in the Laboratory of Bioorganic Chemistry in Bethesda, MD, where he started in October 2020. Cheloha’s work. Dr. Ross Cheloha on the web NIDDK Cheloha Lab Google Scholar LinkedIn Twitter ResearchGate Dr.

. << Back to podcast list Strategic Partner(s) Custom Molecules, Fluorescent Probes: When Chemists Think At Celtarys, the focus is on enabling fast, customizable development of fluorescent ligands and chemical She began as a medicinal chemist in Italy, but a postdoc opportunity in Santiago de Compostela—and a Pivoting: From Chemistry Company to Discovery Partner Initially focused on tool production, Celtarys “We always start with the problem, then generate the right compound using our chemistry.